Emerging evidence suggests that a small subpopulation of tumor cells, identified by the CD44+/CD24−/low cancer stem cell markers expression in breast cancer tissue, have strong abilities of self-renewal and are responsible for tumor aggressiveness, recurrence, metastasis, and therapeutic resistance [45–48]. This evidence concerns the gene CD44 and breast carcinoma.